↓ Skip to main content

Symptomatic efficacy of rasagiline monotherapy in early Parkinson's disease: Post-hoc analyses from the ADAGIO trial

Overview of attention for article published in Parkinsonism & Related Disorders, March 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
67 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Symptomatic efficacy of rasagiline monotherapy in early Parkinson's disease: Post-hoc analyses from the ADAGIO trial
Published in
Parkinsonism & Related Disorders, March 2014
DOI 10.1016/j.parkreldis.2014.02.024
Pubmed ID
Authors

Joseph Jankovic, Elijahu Berkovich, Eli Eyal, Eduardo Tolosa

Abstract

The ADAGIO study included a large cohort of patients with early PD (baseline total-UPDRS = 20) who were initially randomized to rasagiline and placebo, thereby allowing analyses of symptomatic efficacy.

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 1%
Brazil 1 1%
Unknown 65 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 13 19%
Student > Master 10 15%
Student > Doctoral Student 5 7%
Other 5 7%
Student > Ph. D. Student 5 7%
Other 13 19%
Unknown 16 24%
Readers by discipline Count As %
Medicine and Dentistry 22 33%
Agricultural and Biological Sciences 5 7%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Nursing and Health Professions 3 4%
Neuroscience 3 4%
Other 8 12%
Unknown 22 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 March 2014.
All research outputs
#7,196,412
of 25,374,647 outputs
Outputs from Parkinsonism & Related Disorders
#1,137
of 3,100 outputs
Outputs of similar age
#64,377
of 235,875 outputs
Outputs of similar age from Parkinsonism & Related Disorders
#10
of 36 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 3,100 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 235,875 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.